Display options
Share it on

Int J Hematol Oncol Stem Cell Res. 2015 Jul 01;9(3):143-54.

The Newly Identified T Helper 22 Cells Lodge in Leukemia.

International journal of hematology-oncology and stem cell research

Gholamreza Azizi, Mohsen Rastegar Pouyani, Shadi Sadat Navabi, Reza Yazdani, Fatemeh Kiaee, Abbas Mirshafiey

Affiliations

  1. Imam Hassan Mojtaba Hospital, Alborz University of Medical Sciences, Karaj, Iran ; Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
  2. Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
  3. Department of Immunology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran ; Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
  4. Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.

PMID: 26261700 PMCID: PMC4529682

Abstract

Leukemia is a hematological tumor in which the malignant myeloid or lymphoid subsets play a pivotal role. Newly identified T helper cell 22 (Th22) is a subset of CD4(+) T cells with distinguished gene expression, function and specific properties apart from other known CD4(+) T cell subsets.Th22 cells are characterized by production of a distinct profile of effector cytokines, including interleukin (IL)-22, IL-13, and tumor necrosis factor-α (TNF-α). The levels of Th22 and cytokine IL-22 are increased and positively related to inflammatory and autoimmune disorders. Recently, several studies have reported the changes in frequency and function of Th22 in acute leukemic disorders as AML and ALL. This review discusses the role of Th22 and its cytokine IL-22 in the immunopathogenesis of leukemic disease.

Keywords: ALL; AML; IL-22; Leukemia; Th22

References

  1. Zhonghua Xue Ye Xue Za Zhi. 2012 Feb;33(2):133-5 - PubMed
  2. Immunol Rev. 2013 Mar;252(1):116-32 - PubMed
  3. Int Immunol. 2011 Mar;23(3):159-63 - PubMed
  4. Am J Clin Pathol. 2005 Mar;123(3):456-64 - PubMed
  5. Int J Rheum Dis. 2013 Jun;16(3):243-53 - PubMed
  6. J Clin Immunol. 2012 Dec;32(6):1332-9 - PubMed
  7. Proc Natl Acad Sci U S A. 2009 Dec 22;106(51):21795-800 - PubMed
  8. Endocr Metab Immune Disord Drug Targets. 2015;15(3):242-50 - PubMed
  9. Clin Cancer Res. 2008 Oct 15;14(20):6432-9 - PubMed
  10. J Immunol. 2008 Aug 15;181(4):2898-906 - PubMed
  11. Nat Immunol. 2007 Jun;8(6):639-46 - PubMed
  12. Immunol Cell Biol. 2010 Aug;88(6):621-3 - PubMed
  13. Nat Immunol. 2008 Dec;9(12):1347-55 - PubMed
  14. J Biol Chem. 2002 Sep 13;277(37):33676-82 - PubMed
  15. Zhonghua Yi Xue Za Zhi. 2013 May 28;93(20):1537-40 - PubMed
  16. J Clin Invest. 2009 Dec;119(12):3573-85 - PubMed
  17. Proc Natl Acad Sci U S A. 2010 Mar 23;107(12):5540-4 - PubMed
  18. Blood. 2009 Oct 22;114(17):3610-4 - PubMed
  19. Clin Exp Immunol. 2010 Feb;159(2):120-30 - PubMed
  20. Cancer Res. 2010 Dec 15;70(24):10112-20 - PubMed
  21. J Clin Immunol. 1995 May;15(3):121-9 - PubMed
  22. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014 Jun;22(3):873-8 - PubMed
  23. Immunity. 2004 Aug;21(2):241-54 - PubMed
  24. J Huazhong Univ Sci Technolog Med Sci. 2007 Jun;27(3):330-2 - PubMed
  25. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Aug;21(4):857-60 - PubMed
  26. Iran J Allergy Asthma Immunol. 2015 Jun;14(3):246-54 - PubMed
  27. J Exp Med. 2006 Apr 17;203(4):843-9 - PubMed
  28. Cell Immunol. 2010;264(1):97-103 - PubMed
  29. Oncogene. 2002 Feb 7;21(7):1038-47 - PubMed
  30. Clin Exp Immunol. 2009 Nov;158(2):199-204 - PubMed
  31. FASEB J. 2002 Oct;16(12 ):1680-2 - PubMed
  32. Eur J Immunol. 1995 Sep;25(9):2656-60 - PubMed
  33. Mediators Inflamm. 2014;2014:740947 - PubMed
  34. Annu Rev Immunol. 2009;27:485-517 - PubMed
  35. Blood. 2009 Jul 30;114(5):937-51 - PubMed
  36. Nat Immunol. 2009 Aug;10(8):864-71 - PubMed
  37. Mucosal Immunol. 2013 May;6(3):626-38 - PubMed
  38. Vet Clin North Am Small Anim Pract. 2010 May;40(3):369-79 - PubMed
  39. Nat Immunol. 2008 Dec;9(12):1341-6 - PubMed
  40. PLoS One. 2012;7(4):e31000 - PubMed
  41. Leukemia. 2008 Aug;22(8):1595-603 - PubMed
  42. Zhonghua Xue Ye Xue Za Zhi. 2012 Dec;33(12):985-8 - PubMed
  43. Ann Allergy Asthma Immunol. 2000 Jul;85(1):9-18; quiz 18, 21 - PubMed
  44. Nat Immunol. 2009 Aug;10(8):857-63 - PubMed
  45. Eur J Immunol. 2010 Sep;40(9):2450-9 - PubMed
  46. Science. 1994 Aug 26;265(5176):1237-40 - PubMed
  47. Lancet Oncol. 2005 May;6(5):322-7 - PubMed
  48. Cytokine Growth Factor Rev. 2014 Jun;25(3):257-71 - PubMed
  49. J Exp Med. 2009 Jan 16;206(1):35-41 - PubMed
  50. Nature. 2009 Feb 5;457(7230):722-5 - PubMed
  51. Leukemia. 2000 Sep;14(9):1533-59 - PubMed
  52. J Clin Invest. 1996 Jul 1;98(1):70-7 - PubMed
  53. J Allergy Clin Immunol. 2009 Jun;123(6):1244-52.e2 - PubMed
  54. J Leukoc Biol. 2005 Sep;78(3):656-64 - PubMed
  55. Leukemia. 2012 Mar;26(3):422-3 - PubMed
  56. PLoS One. 2012;7(12):e51339 - PubMed
  57. Immunol Rev. 2008 Dec;226:160-71 - PubMed
  58. Blood. 2011 Jan 13;117(2):575-84 - PubMed
  59. Clin Dev Immunol. 2012;2012:925135 - PubMed
  60. J Immunol. 2011 Nov 15;187(10):5026-31 - PubMed
  61. Proc Natl Acad Sci U S A. 2010 Mar 30;107(13):5943-8 - PubMed
  62. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2012 Dec;28(12):1314-6 - PubMed
  63. Int Immunol. 2013 Oct;25(10):547-51 - PubMed
  64. Leuk Res. 2000 Jul;24(7):611-21 - PubMed
  65. Arthritis Rheum. 2009 Jun;60(6):1647-56 - PubMed
  66. Zhonghua Xue Ye Xue Za Zhi. 2010 Sep;31(9):617-20 - PubMed
  67. Int J Mol Sci. 2014 Jan 27;15(2):1927-45 - PubMed
  68. J Clin Immunol. 2008 Nov;28(6):647-59 - PubMed
  69. Hum Immunol. 2012 Aug;73(8):795-800 - PubMed
  70. Transplantation. 2004 Jan 27;77(2):311-3 - PubMed
  71. Hematology Am Soc Hematol Educ Program. 2004;:118-45 - PubMed
  72. J Immunol. 1986 Apr 1;136(7):2348-57 - PubMed
  73. Adv Exp Med Biol. 2013;788:321-8 - PubMed
  74. Cell. 2000 Mar 17;100(6):655-69 - PubMed
  75. Semin Immunol. 2007 Dec;19(6):383-93 - PubMed
  76. Clin Exp Rheumatol. 2013 May-Jun;31(3 Suppl 77):32-40 - PubMed
  77. Cancer Immunol Immunother. 2012 Nov;61(11):1965-75 - PubMed
  78. Med Health R I. 2003 Aug;86(8):243-6 - PubMed
  79. Cell. 2004 May 14;117(4):515-26 - PubMed
  80. Eur J Immunol. 2011 Sep;41(9):2596-605 - PubMed
  81. Arch Immunol Ther Exp (Warsz). 2005 Jul-Aug;53(4):357-63 - PubMed
  82. J Biol Chem. 2001 May 25;276(21):17779-87 - PubMed
  83. J Neuroimmunol. 2013 Aug 15;261(1-2):87-91 - PubMed
  84. Cytokine. 2015 May;73(1):66-73 - PubMed
  85. Mol Cell Biochem. 2011 Jul;353(1-2):41-6 - PubMed
  86. Sci Transl Med. 2014 Jan 15;6(219):219ra8 - PubMed
  87. Am J Clin Pathol. 2011 Aug;136(2):282-8 - PubMed
  88. Cancer Sci. 2014 Aug;105(8):933-42 - PubMed
  89. Arthritis Res Ther. 2013 Sep 26;15(5):R136 - PubMed
  90. Mediators Inflamm. 2014;2014:813926 - PubMed
  91. Immunol Rev. 2001 Aug;182:207-14 - PubMed
  92. Annu Rev Immunol. 2007;25:821-52 - PubMed
  93. Clin Dev Immunol. 2013;2013:915873 - PubMed
  94. Arthritis Res Ther. 2011;13(5):R166 - PubMed
  95. Blood Cells Mol Dis. 2013 Jan;50(1):39-40 - PubMed
  96. Blood. 2008 Sep 1;112(5):1557-69 - PubMed
  97. Nat Immunol. 2001 Aug;2(8):671-2 - PubMed
  98. Immunity. 2003 Aug;19(2):165-8 - PubMed
  99. Clin J Oncol Nurs. 2000 Sep-Oct;4(5):233-4, 236 - PubMed
  100. Immunity. 2013 Oct 17;39(4):744-57 - PubMed
  101. Clin Chim Acta. 2013 Nov 15;426:108-13 - PubMed
  102. Hum Immunol. 2014 Feb;75(2):113-8 - PubMed

Publication Types